Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05281627
Other study ID # 8160
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 15, 2021
Est. completion date September 30, 2024

Study information

Verified date March 2023
Source Cardiff and Vale University Health Board
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An emergency laparotomy (EmLap) is a life-saving operationÍž but the aftermath for those that do survive can be lifechanging. Each year, in excess of 25,000 EmLaps are performed in UK. A national effort, through the National Emergency Laparotomy Audit (NELA), has managed to improve peri-operative care, and reduce 30 day mortality from 1 in 4 to less than 1 in 10. Whilst this reduction should be commended, it also means that more patients are surviving with some form of new infirmity. This infirmity may be short-lived and reversible in some, and yet others may transition into a permanent chronic disease state. The impact of EmLap on those individuals that "do not fully recover" is far-reaching and often interlinked, covering biological, social and psychological domains. This makes it difficult to describe the true problem, i.e. holistic morbidity and suggest an intervention to improve it. The primary aim of this work is to describe the holistic morbidity of EmLap throughout the first year of a patient's recovery.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 175
Est. completion date September 30, 2024
Est. primary completion date September 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or above - Able to communicate in English - Cognitively able to complete the questionnaire - Able to provide informed voluntary consent - Undergone an EmLap during admission - Clinical team anticipate to be "medically fit for discharge" within 48 hours (of consent) Exclusion Criteria: - Any terminal diagnosis in which the clinical team do not anticipate life expectancy to exceed 6 months from the time of surgery - Acutely unwell at the time of recruitment. These patients may still be eligible and can be re-screened and recruited at a later date, should their condition improve.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Emergency Laparotomy
All patients undergoing Emergency Laparotomy

Locations

Country Name City State
United Kingdom Julie Cornish Cardiff
United Kingdom Royal Alexandra Hospital Paisley Renfrewshire

Sponsors (3)

Lead Sponsor Collaborator
Cardiff and Vale University Health Board NHS Greater Glasgow and Clyde, The Royal College of Surgeons of England

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Overall patient experience of Emergency Laparotomy care as assessed by the NHS Wales Experience Questionnaire Patient experience will be assessed at a 3 time-points during the course of their recovery at the end of the study using the NHS Wales Patient Experience questionnaire. Overall experience is measured on 10-point Likert scale (0-least satisfied, 10 most satisfied). 12 months
Other Number of patient points of care Incidence of scheduled and unscheduled care will be measured over the course of the patients involvement in the project 12 months
Primary The change in patient reported Quality of Life as assessed by the EuroQuol 5-Dimension Health-related Quality of Life instrument (EQ-5D) Patient reported Quality of Life will be measured at 3 time points post-discharge. Reduction of EQ-5D 3-Level scale (min.5; max 15) and EQ-5D Visual Analogue Scale (min 0; max. 100) represent improved quality of life. 12 months
Secondary Establishing the patient definition of 'Recovery' following Emergency Laparotomy using qualitative methods Semi-structured qualitative interviews will be conducted with approximately 15 Emergency Laparotomy patients, at 6-months post-discharge from hospital. The interview will evaluate:
A) what patients consider to constitute 'recovery' following emergency laparotomy B) what factors influence achieving 'recovery' C) the timelines linked to a) and b)
12 months
Secondary Change in Fatigue Severity Score Fatigue severity score (FSS) to assess physical health. Measured at 3 time-points post-operatively and scored from 9 (min.) to 63 (max.), with increase in total score represents greater fatigue severity/ reduced physical health. 12 months
Secondary Change in Body Mass Index Body Mass Index (BMI) to assess physical health. Weight and Height will be recorded in kg and cm (respectively) at 3 time-points and BMI will be calculated and reported in terms of kg/m^2. 12 months
Secondary Change in Rockwood Frailty Score Rockwood Frailty Score to asses physical health. Collected at 3 time-points and scored from 1 (min.) to 9 (max.), where greater score represents increased frailty. Only validated for use in the over 65's 12 months
Secondary Change in Gastro-Intestinal Quality of Life Index Gastro-intestinal Quality of Life Index (GIQLI) to assess in physical health. Collected at 3 time-points, total score calculated from 0 (min.) to 144 ( max.), where greater total score represents improved GI health related QoL. 12 months
Secondary Change in International Trauma Questionnaire score International Trauma Questionnaire to assess mental-health. Collected at 3 timepoints. Scored in accordance with assessment guidance to determine clinical signs of (complex) Post-Traumatic Stress Disorder. 12 months
Secondary Change in Patient Health Questionnaire score Patient Health Questionnaire (PHQ9) to assess mental-health. Collected at 3 timepoints and scored from 0 (min.) to 27 (max.), where greater score represents increased depression severity. 12 months
Secondary Change in Generalised Anxiety Disorder assessment score Generalised Anxiety Disorder assessment (GAD7) to assess mental-health. Measured at 3 timepoints from 0 (min.) to 21 (max.), where greater score represents increased anxiety severity. 12 months
Secondary Changes in Community Integration Questionnaire score Community Integration Questionnaire (CIQ) to determine changes in social integration. Scored between 0 (min.) and 35 (max.), where greater score represents reduced social integration. 12 months
Secondary Change in sexual function Single question regarding change in sexual function (min 0; max 5), where greater score represents increased sexual impairment 12 months
Secondary Change in employment status Single question regarding change in employment status (yes/no). 12 months
Secondary The changes in care burden as assessed by the Modified Caregiver Strain Index (MCSI) Caregiver- reported burden will be measured at 3 timepoints post-discharge. Increase in total score of the Modified Caregiver Strain Index (MCSI) (min. 0; max. 26), represents greater burden on caregiver. 12 months
See also
  Status Clinical Trial Phase
Completed NCT04615520 - Evaluation of Surgical Risk Prediction Tools.
Recruiting NCT04878159 - Troponin T and Emergency High-risk Abdominal Surgery
Recruiting NCT04403425 - Tissue Perfusion During Emergency Laparotomy
Active, not recruiting NCT04311788 - Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial N/A